Market Cap (In CNY)
2.97 Billion
Revenue (In CNY)
565.4 Million
Net Income (In CNY)
-42.89 Million
Avg. Volume
1.63 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.53-8.54
- PE
- -
- EPS
- -
- Beta Value
- 0.253
- ISIN
- CNE000000QQ8
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Yajuan Ju
- Employee Count
- -
- Website
- https://www.ginwa.com.cn
- Ipo Date
- 1997-06-12
- Details
- Ginwa Enterprise (Group) Inc. researches, develops, produces, and sells proprietary Chinese, biological, and chemical medicines in China. It offers orthopedic, immune, pediatric, antibiotic, digestive system, gynecological, cardiovascular, antipyretic, analgesic, antiviral, and other products. The company provides its products in the form of capsules, powders, and tablets. Ginwa Enterprise (Group) Inc. is based in Xi'an, China.
More Stocks
-
SLGWFSLANG Worldwide Inc.
SLGWF
-
3141
-
HTHIYHitachi, Ltd.
HTHIY
-
ALL-PHThe Allstate Corporation
ALL-PH
-
SISSIS Limited
SIS
-
600362
-
6495Nanoplus Ltd.
6495
-
SHD